Microbix signs distributor for Kinlytic
November 17, 2009 by leonardzehr · Leave a Comment
Microbix Biosystems (TSX:MBX) has landed Riso Pharma to distribute its Kinlytic drug in the Middle East, with Riso guaranteeing to purchase no less than 50,000 vials of the treatment for pulmonary embolism over the next three years. Sales are expected to begin in mid-2010. “While final pricing for our therapy has not yet been established, [...]
Listen to BioTuesdays 
